Zion Market Research has published a new report titled “Global Platelet Aggregation Devices Market by Product (Systems, Reagents and Consumables & Accessories), by Application (Clinical and Research), by End-User (Standalone Hospitals, Diagnostic Laboratories, Research & Academic Institutes and Other End-Users): Global Industry Perspective, Comprehensive Analysis and Forecast, 2016 – 2022.” According to the report, the global platelet aggregation devices market accounted for USD 216.3 million in 2016 and is expected to reach USD 427.0 million by 2022, growing at a CAGR of around 20.1% between 2017 and 2022.
Platelets are a component of blood whose function is to form blood clots by sticking together along with the coagulation factors. The main function of platelets is to contribute to hemostasis: the process of stopping bleeding at the site of interrupted endothelium. In addition, they play a crucial role in the inflammation and other pathological situations in conjunction with other cells. With platelet disorders, there may be too many or too few platelets or platelets that do not function well. Some conditions cause changes in both the number and function of platelets. A platelet disorder causes the abnormality in blood clotting function. These disorders can be natural i.e. by birth or acquired during the lifetime due to another disease or condition. Platelet aggregation can be examined through specific tests which have to be conducted before a surgery to diagnose any abnormality in the platelet by using various platelet aggregation devices which in turn expected to fuel the growth in platelet aggregation devices market.
Request Free Sample Research Report @ https://www.zionmarketresearch.com/sample/platelet-aggregation-devices-market
The major drivers for platelet aggregation devices market include increasing demand for platelet screening programs to identify diseases like HIV, Dengue etc. In addition, the market is also expected to fuel demand from the patient population undergoing antiplatelet therapy. Apart from this, increasing geriatric population globally coupled with the growing incidences of target diseases are also expected to boost this market in coming five years. Furthermore, the wide range of new applications of platelet aggregation devices such as assessment of surgical bleeding risk, identification of genetically acquired platelet defects etc. are also expected to drive the market growth within the forecast period. However, the high cost of purchase and limited scope at the level of end users are expected to hamper the market growth in coming five years. In spite of these restraints, research and development in the platelet devices market are expected to be an opportunity for this market in the forecast period.
Platelet aggregation product segment was dominated by platelet aggregation systems and accounted for the largest share of the global market in 2016 and expected to grow at a high rate of CAGR within the forecast period. Systems demand is expected to fuel by the increasing automation of platelet aggregation testing procedures. Furthermore, growing adoption & market preference for automated systems among diagnostic laboratories is also expected to create the demand for systems in this market in coming five years.
The application segment is expected to lead to clinical applications due to increasing awareness among healthcare professionals about the benefits of platelet healthcare devices. In addition, the increasing incidences of the target diseases coupled with increasing the geriatric population globally are also expected to create the demand for platelet aggregation devices in clinical application in coming five years.
The largest market share of the global platelet aggregation devices market of the end-user segment is captured by the standalone hospitals and also expected to grow at a significant CAGR within the forecast period. The demand for platelet aggregation devices in standalone hospitals is expected to supplement by increasing patient population base for diseases such as bleeding disorders, cardiovascular diseases, and arthritis. Demand for these devices in standalone hospitals is expected to follow by the diagnostic laboratories owing to the increasing awareness among diagnostic technicians regarding the benefits of platelet aggregation devices in the diagnosis of various diseases.
In terms of geography, North America accounted for the largest share of platelet aggregation devices market in 2016. It is also expected to grow at the highest CAGR within the forecast period. U.S. holds the largest market share of this market in North America owing to the presence of leading manufacturers in this region. In addition, large patient population for target diseases; growing number of surgical procedures; increasing awareness among healthcare professionals (regarding the benefits offered by platelet aggregation testing in disease diagnosis); significant number of patients undergoing cardiovascular surgeries; and increasing prevalence of orthopedic, urological, and bleeding disorders are also expected to drive the growth in this market in coming five years.
Browse the full report at https://www.zionmarketresearch.com/report/platelet-aggregation-devices-market
North America is expected to be followed by Europe within the forecast period owing to the presence of leading manufacturers supplemented by a large number of patients suffering from cardiovascular diseases, neoplasm & strokes. Asia-Pacific is expected as a lucrative market for platelet aggregation devices in coming five years, especially India, owing to the increasing awareness among healthcare professionals about the benefits of platelet aggregation testing in disease diagnosis. Latin America and Middle East & Africa are also expected to gain an above average growth in this market within the forecast period.
The report presents comprehensive competitive outlook with company profiles of the key players operating in the global market. Key participants profiled in the report include Siemens AG, Helena Laboratories Corporation, Haemonetics Corporation, Accriva Diagnostics, F. Hoffman-La Roche Ltd, Helena Laboratories Corporation, Sysmex Corporation, Aggredyne, Inc., TEM Group, Sentinel Ch. S.P.A. among others.
About Us: Zion Market Research is an obligated company. We create futuristically, cutting edge, informative reports ranging from industry reports, a company reports to country reports. We provide our clients not only with market statistics unveiled by avowed private publishers and public organizations but also with Vogue and newest industry reports along with pre-eminent and niche company profiles. Our database of market research reports comprises a wide variety of reports from Cardinal Industries. Our database is been updated constantly in order to fulfill our clients with prompt and direct online access to our database. Keeping in mind the client’s needs, we have included expert insights on global industries, products, and market trends in this database. Last but not the least, we make it our duty to ensure the success of clients connected to us—after all—if you do well, a little of the light shines on us.
Zion Market Research
4283, Express Lane,
Sarasota, Florida 34249, United States
Tel: +49-322 210 92714
USA/Canada Toll-Free No.1-855-465-4651